Skip to content

Clinical trials

Dermatomyositis trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatomyositis Country / region: Japan Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20131
20141
20171
20181
20192
20211
20221
20232
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting5
Terminated4
Enrolling by invitation2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Chugai Pharmaceutical2
Novartis Pharmaceuticals2
Pfizer2
argenx2
Alexion Pharmaceuticals, Inc.1
Astellas Pharma Inc1
Bristol-Myers Squibb1
CSL Behring1
Corbus Pharmaceuticals Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatomyositis18
Polymyositis10
Myositis5
Lung Diseases, Interstitial3
Antiphospholipid Syndrome2
Behcet Syndrome2
Pemphigoid, Bullous2
Purpura, Thrombocytopenic, Idiopathic2
Arthritis1
Arthritis, Rheumatoid1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.